Monitoring of biomarkers in heart failure

The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of...

Descripción completa

Detalles Bibliográficos
Autores principales: Spoletini, Ilaria, Coats, Andrew J S, Senni, Michele, Rosano, Giuseppe M C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937510/
https://www.ncbi.nlm.nih.gov/pubmed/31908607
http://dx.doi.org/10.1093/eurheartj/suz215
_version_ 1783483890594217984
author Spoletini, Ilaria
Coats, Andrew J S
Senni, Michele
Rosano, Giuseppe M C
author_facet Spoletini, Ilaria
Coats, Andrew J S
Senni, Michele
Rosano, Giuseppe M C
author_sort Spoletini, Ilaria
collection PubMed
description The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.
format Online
Article
Text
id pubmed-6937510
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-69375102020-01-06 Monitoring of biomarkers in heart failure Spoletini, Ilaria Coats, Andrew J S Senni, Michele Rosano, Giuseppe M C Eur Heart J Suppl Articles The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF. Oxford University Press 2019-12 2019-12-31 /pmc/articles/PMC6937510/ /pubmed/31908607 http://dx.doi.org/10.1093/eurheartj/suz215 Text en Published on behalf of the European Society of Cardiology. © The Author(s) 2019. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Articles
Spoletini, Ilaria
Coats, Andrew J S
Senni, Michele
Rosano, Giuseppe M C
Monitoring of biomarkers in heart failure
title Monitoring of biomarkers in heart failure
title_full Monitoring of biomarkers in heart failure
title_fullStr Monitoring of biomarkers in heart failure
title_full_unstemmed Monitoring of biomarkers in heart failure
title_short Monitoring of biomarkers in heart failure
title_sort monitoring of biomarkers in heart failure
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937510/
https://www.ncbi.nlm.nih.gov/pubmed/31908607
http://dx.doi.org/10.1093/eurheartj/suz215
work_keys_str_mv AT spoletiniilaria monitoringofbiomarkersinheartfailure
AT coatsandrewjs monitoringofbiomarkersinheartfailure
AT sennimichele monitoringofbiomarkersinheartfailure
AT rosanogiuseppemc monitoringofbiomarkersinheartfailure

Ejemplares similares